Another AI startup helping providers automate administrative processes picked up a significant round of capital on Thursday. San Francisco-based Luminai snagged $38 million in Series B funding, bringing its fundraising …
Category:
Health
-
-
Many cancer drugs work by blocking proteins associated with tumor progression, but there’s growing industry interest in drugs that eliminate such proteins altogether. Gilead Sciences and Roche have both dipped …
-
Every primary care physician knows the moment. A patient – say, a 60-year-old woman who suffers from heart failure and diabetes – is seeking treatment for a headache, fever, or …
-
Philadelphia-based health system Jefferson Health is suing Aetna, claiming the payer is unfairly reducing payments for some hospital stays under Medicare Advantage. Aetna said that it has done nothing wrong. …
-
In June of 2025, health plans made a series of commitments to improve prior authorization. On Tuesday, insurer advocacy organization AHIP and Blue Cross Blue Shield Association gave their first …
-
Insmed’s new drug, Brinsupri, is still projected to reach blockbuster status, but an inflammatory skin disorder is no longer in the picture following a mid-stage clinical trial failure in this …
-
The $50 billion in CMS awards for rural health transformation (RHT) are starting to roll out across the nation. These grants are intended to fund “comprehensive strategies to improve care …
-
In 2016, patient non-adherence was estimated to cost U.S. pharmaceutical companies a staggering $250 billion in potential annual sales. Why does this issue still persist nearly a decade later? For …
-
Value-based care and Medicare Advantage are often heralded as two of healthcare’s most promising strategies for controlling costs, but industry leaders can’t quite tell if they’re actually working. During a …
-
Gilead Sciences is building out its pipeline through a multi-billion dollar deal to acquire Tubulis, a startup with two targeted therapies in clinical testing. While those therapies are in development …